MX9604072A - Derivados de oxazolidinona y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de oxazolidinona y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9604072A
MX9604072A MX9604072A MX9604072A MX9604072A MX 9604072 A MX9604072 A MX 9604072A MX 9604072 A MX9604072 A MX 9604072A MX 9604072 A MX9604072 A MX 9604072A MX 9604072 A MX9604072 A MX 9604072A
Authority
MX
Mexico
Prior art keywords
compositions containing
pharmaceutical compositions
oxazolidinone derivatives
present
derivatives
Prior art date
Application number
MX9604072A
Other languages
English (en)
Other versions
MXPA96004072A (es
Inventor
Hiroyoshi Yamada
Kiyotaka Munesada
Mikio Taniguchi
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX9604072A publication Critical patent/MX9604072A/es
Publication of MXPA96004072A publication Critical patent/MXPA96004072A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion proporciona agentes que tienen una alta actividad antimicrobiana para la prevencion y tratamiento de enfermedades infecciosas. De este modo, la presente invencion proporciona derivados nuevos de oxazolidinona representados por la formula química: (Ver Formula) o sales farmacéuticamente aceptables de los mismos, así como composiciones antimicrobianas que contienen como ingredientes activos, dichos derivados o las sales de los mismos.
MXPA/A/1996/004072A 1994-03-15 1996-09-13 Derivados de oxazolidinona y composiciones farmaceuticas que los contienen MXPA96004072A (es)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP6-43949 1994-03-15
JP6/43949 1994-03-15
JP4394994 1994-03-15
JP14656594 1994-06-28
JP6-146565 1994-06-28
JP6/146565 1994-06-28
JP6/235167 1994-09-29
JP6-235167 1994-09-29
JP6235167A JPH0873455A (ja) 1994-03-15 1994-09-29 オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
PCT/US1995/002972 WO1995025106A1 (en) 1994-03-15 1995-03-14 Oxazolidinone derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
MX9604072A true MX9604072A (es) 1997-09-30
MXPA96004072A MXPA96004072A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
DE69529670T2 (de) 2003-09-18
JP3628329B2 (ja) 2005-03-09
LV13155B (en) 2004-06-20
CA2183972A1 (en) 1995-09-21
DE69529670D1 (de) 2003-03-27
EP0750618A1 (en) 1997-01-02
PT750618E (pt) 2003-06-30
JPH09512785A (ja) 1997-12-22
DK0750618T3 (da) 2003-06-10
CA2183972C (en) 2005-07-05
JPH0873455A (ja) 1996-03-19
ES2191048T3 (es) 2003-09-01
ATE232862T1 (de) 2003-03-15
WO1995025106A1 (en) 1995-09-21
KR100340365B1 (ko) 2002-11-23
NZ283011A (en) 1997-09-22
EP0750618B1 (en) 2003-02-19
AU2099995A (en) 1995-10-03
CN1143961A (zh) 1997-02-26
AU681953B2 (en) 1997-09-11

Similar Documents

Publication Publication Date Title
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
DE60112609D1 (en) Pyrazolopyridine
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
NO971471L (no) Nye karboksamider med fungicid aktivitet
ATE248837T1 (de) Chinuclidin-acrylamide
NO950297L (no) Prolinamidderivater
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
NZ515669A (en) Beta 2 adrenoceptor agonists
MXPA04000577A (es) Derivados de dolastatina 10.
HK1003708A1 (en) Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
DE60112330D1 (en) Pyrazolopyridinderivate
NO996108L (no) 9-oksinerytromycinderivater
DE69631609D1 (en) Tricyclische erythromycinderivate
PE20001297A1 (es) Antibioticos cetolidos carbamato y carbazato
FI903153A0 (fi) 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
CA2248794A1 (en) Medicament for preventive and treatment for viral infectious diseases
AU4146000A (en) Remedies for glomerulosclerosis
ES2179668T3 (es) Un compuesto wf002, su produccion y su uso.
IT1301967B1 (it) Derivato di eritromicina ad attivita' antibiotica
IL150181A0 (en) Quaternary ammonnium and their-tussive agent